Oral Peanut Allergy Tx OK'd

12:59 EST 31 Jan 2020 | MedPageToday

]]>(MedPage Today) -- WASHINGTON -- Aimmune Therapeutics' oral immunotherapy for peanut allergy gained FDA approval late Friday, for treating individuals age 4-17, the agency said. To be sold as Palforzia, the product consists of purified peanut...

Original Article: Oral Peanut Allergy Tx OK'd


More From BioPortfolio on "Oral Peanut Allergy Tx OK'd"

Quick Search

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...